All funding news
R

RQ Bio

🇺🇰UKBiotech

RQ Bio develops cell therapy manufacturing technology for biotech and pharma companies.

Rounds tracked
1

Funding history

R
🇺🇰RQ BioBiotech

RQ Bio develops cell therapy manufacturing technology for biotech and pharma companies.

$108.6MSeries A
Investor undisclosed
A $108M Series A for manufacturing tech (not the therapy itself) signals that cell therapy scaling has moved from R&D bottleneck to commercialization bottleneck—investors are betting the hard part now is making it at volume, not inventing it. If you're building biotech infrastructure, this validates that the market will pay for solutions that compress manufacturing timelines and costs, not just efficacy gains.

Want a deeper look at RQ Bio?

Ask Dormy who's likely on their cap table, what kind of companies their lead investor backs, and how to reach them.

Ask in Telegram →